Abnormal PD-L1 expression is used as a biomarker for early diagnosis and progression of several malignant tumors [36], such as lung cancer [37], thyroid cancer [38] and head and neck squamous cell carcinoma [39]. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.